Neurotensin (NT) endopeptidase (EC 3.4.24.16) has been purified about 800-fold from pig brain by four sequential chromatographic steps depending on ion-exchange and hydrophobic interactions. Two types of preparation were studied: one from a Triton X-100-solubilized membrane fraction, and the other from the soluble fraction containing 90 % or more of the total activity in the homogenate. NT endopeptidase activity was monitored by high-precision liquid chromatography of the two peptide products, characterized as NT-(1-10) and NT-(1-8), resulting from cleavage of the Pro'0-Tyr" and Arg8-Arg9 bonds respectively. As purification proceeded, from both membranes and cytosol, the yield of the two products achieved a constant ratio of 5: 1 and this ratio was reproduced in repeated purifications. However, a distinct peptidase which hydrolysed exclusively at the Arg8-Arg9 bond was partially resolved from NT endopeptidase by chromatography on hydroxyapatite, and this activity was further purified and assigned to endopeptidase-24. 15 (EC 3.4.24.15). SDS/PAGE of both preparations of neurotensin endopeptidase revealed a major band of apparent Mr 75000, and treatment of the membrane-associated form with N-Glycanase gave no evidence that the enzyme was a glycoprotein. The membraneassociated and cytosol forms of NT endopeptidase activities, monitored for both NT-(1-10) and NT-(1-8) products, were compared in their responses to 1,10-phenanthroline, EDTA, dithiothreitol (DTT) and some synthetic site-directed inhibitors of endopeptidase-24. 15 or peptidyl dipeptidase A. The effects revealed no significant differences between the two preparations, nor did the reagents discriminate between the activities generating the two NT fragments. The partially purified form of endopeptidase-24.15 was also included in this comparison: while some responses were similar, this peptidase was distinguishable in its activation by DTT and its relative resistance to inhibition by EDTA. Both forms of NT endopeptidase were found to hydrolyse other substrates, including Boc-Phe-Ala-Ala-Phe-4-aminobenzoate, bradykinin and substance P (these at faster rates than neurotensin), as well as dynorphin A-(1-8) and luliberin. The bonds hydrolysed in these neuropeptides, as well as in angiotensins I and II and a-neoendorphin, were defined. These studies confirm that NT endopeptidase is distinct from endopeptidase-24.15. They further show that the former is a soluble enzyme, not an integral membrane protein, that it is not peptide-specific and that it might be more appropriately named.
INTRODUCTION
The tridecapeptide neurotensin (NT) fulfils many of the criteria for action as a neurotransmitter in the central nervous system. Thus it is distributed heterogeneously in the brain (Emson et al., 1982) and, on subcellular fractionation, is associated with synaptosomes (Uhl & Snyder, 1976) . The peptide can be released from tissue slices following depolarization in the presence of Ca2+ (Iversen et al., 1978) , and specific NT receptors have been located autoradiographically in the nervous system (Young & Kuhar, 1981) . Finally, NT is rapidly inactivated by brain homogenates and membrane fractions from brain (McDermott et al., 1982) . Checler et al. (1983 Checler et al. ( , 1984 Checler et al. ( , 1985 have examined the pathway of catabolism of NT by synaptic membrane preparations from rat brain in order to identify the peptidases responsible for its inactivation. Several peptidases appear to contribute to NT degradation, with hydrolysis being initiated at the Arg8-Arg9, Pro'0-Tyr" and Tyr"-Ile"2 bonds, producing biologically inactive fragments of the peptide (Checler et al., 1983 (Checler et al., , 1985 .
Hydrolysis at the Arg8-Arg9 bond has been attributed to (Checler et al., 1985) , a metalloendopeptidase described by Orlowski et al. (1983) and recently shown to be identical to oligoendopeptidase A and Pz peptidase . This enzyme shows a complex specificity, with a preference for Laromatic residues in positions Pl, P2 and P'3. It is also strongly inhibited by several site-directed inhibitors such as N-[l-(RS)-carboxy-2-phenylethyl]-Ala-Ala-Phe-p-aminobenzoate (CFEAAFpAB) (Chu & Orlowski, 1984) . Hydrolysis of both the Pro'0-Tyr" and Tyr"-Ile"2 bonds of NT is catalysed by endopeptidase-24.11 in vitro, and specific endopeptidase inhibitors have been shown to potentiate the hypothermic effect of exogenously administered NT in vivo (Coquerel et al., 1986) . However, phosphoramidon only partially abolishes hydrolysis of the Pro'0-Tyr"1 bond by synaptic membranes, suggesting the involvement of a second activity. This activity, designated NT endopeptidase (EC 3.4.24.16) , has been purified from rat brain synaptic membranes and reported to be a metalloendopeptidase distinct from both endopeptidase-24.11 and endopeptidase-24.15 (Checler et al., 1986; Barelli et al., 1988a) . Peptidyl dipeptidase A (angiotensin-converting enzyme) can cleave the Tyr"-Ile"2 bond of NT in vitro. However, it does not appear to initiate NT metabolism but, rather, plays a secondary role in generating the NT-(1-8) fragment from NT-(1-10) (Checler et al., 1984) .
The present study demonstrates that the activities purified from the cytosol and membrane fractions of pig brain contain a single activity resembling NT endopeptidase. In particular, the substrate specificities and inhibitor sensitivities were identical for Vol. 276 583 Abbreviations used: Boc, t-butyloxycarbonyl; BocFAAFpAB, Boc-Phe-Ala-Ala-Phe-4-aminabenzoate; BzGAAFpAB, benzoyl-Gly-Ala-Ala-Phe-4-aminobenzoate; CFE-AAFpAB, N-[1-(R,S)-carboxy-2-phenylethyl]-Ala-Ala-Phe-4-aminobenzoate; CFP-AAFpAB, N-[l-(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-4-aminobenzoate; CFP-AAYpAB, N-[l-(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Tyr-4-aminobenzoate; Dip-F, di-isopropyl fluorophosphate; LHRH, luliberin (luteinizing-hormone-releasing hormone); NT, neurotensin; pAB, 4-aminobenzoate; DTT, dithiothreitol.
* To whom correspondence and reprint requests should be addressed. the membrane-associated and soluble peptidases, but could be differentiated from endopeptidase-24.15 partially purified from the cytosol. EXPERIMENTAL 
Materials
Peptides and substrates were purchased from Sigma Chemical Co., as were amastatin and di-isopropyl fluorophosphate (Dip-F). Phosphoramidon was from the Peptide Institute, Osaka, Japan. BzGAAFpAB, BocFAAFpAB, CFE-AAFpAB, CFPAAFpAB and CFP-AAYpAB were generously donated by Dr Fresh pig brain without the cerebellum (800 g) was homogenized in 3.5 litres of 10 mM-Tris/HCl buffer, pH 7.5, containing 150 mM-NaCl and centrifuged at 3000 g for 15 min to remove cellular debris. The supernatant was centrifuged at 17000 g for 120 min and the resulting pellet was resuspended in 480 ml of deionized water prior to the addition of 160 ml of 10 mM-Tris/HCI buffer, pH 7.5, containing 2 M-NaCl. The suspension was further centrifuged at 28000 g for 60 min and the resultant pellet was washed with 500 ml of 10 mM-Tris/HCI buffer, pH 7.5. The membrane pellet was then solubilized by stirring for 30 min at 4°C with 900 ml of 20 mM-Tris/HCI buffer/3 % (w/w) Triton X-100, pH 7.5 (detergent/protein ratio 6: 1) and centrifuged at 28 000 g for 60 min to remove insoluble material.
Purification of membrane-associated NT-degrading activity
The purification procedure was modified from that described by Checler et al. (1986) . The solubilized membrane fraction was applied to a DEAE-cellulose column (160 ml bed volume) equilibrated with 20 mM-Tris/HCI buffer, pH 7.5, and washed with the same buffer until the A280 of the eluant fell to zero. This buffer and those in all subsequent steps contained no detergent. A linear gradient of NaCl (200 ml of 75 mM-NaCI/200 ml of 175 mM-NaCI) was applied to the column at a flow rate of 2.5 ml/min and fractions (4 ml) containing NT-degrading activity were pooled, concentrated by ultrafiltration and dialysed against 1 mM-potassium phosphate buffer, pH 7.0. The sample was applied to a hydroxyapatite column (HA-Ultrogel; bed volume 60 ml) equilibrated in the same buffer and subsequently eluted with a linear gradient (2 x 125 ml) from I to 250 mmpotassium phosphate buffer, pH 7, at a flow rate of 2 ml/min. Fractions (2.5 ml) containing NT-degrading activity were pooled, concentrated by ultrafiltration and dialysed against 20 mmTris/HCl buffer, pH 7.0. The sample was then applied to a MonoQ column and eluted with a linear gradient from 0 to 500 mM-NaCl (2 x 15 ml) in 20 mM-Tris/HCl buffer, pH 7.0. To the pooled active fractions was added an equal volume of 4 M-(NH4)2SO4 in 20 mM-Tris/HCI buffer, pH 7.0, and this was applied to an alkyl-Superose column equilibrated with 50 mmpotassium phosphate buffer, pH 7.0, containing 2 M-(NH4)2SO4. A descending gradient (2 x 12.5 ml) of (NH4)2SO4 (2 M to zero) in 50 mM-potassium phosphate buffer, pH 7.0, was used to elute enzyme activity. Freezing caused loss of activity; therefore the pooled fraction was stored at 4°C. At this temperature, the enzyme still showed a gradual loss of activity, and this effect was greater in dilute preparations, e.g. 50 % loss in activity occurred within 24 h. The addition of bovine serum albumin (1 mg/ml) improved the stability, but all assays were performed within 7 days of the final purification step.
Purification of soluble NT-degrading activity
Fresh pig brain (200 g) excluding the cerebellum was homogenized in 1.2 litres of 20 mM-Tris/HCI buffer, pH 7.5, and then centrifuged at 3000 g for 15 min. The supernatant fraction was applied to a DEAE-cellulose column (bed volume 100 ml) pre-equilibrated with 20 mM-Tris/HCI buffer, pH 7.5. The column was washed with equilibration buffer until the A280 of the eluant fell to zero. Protein was then eluted with a linear gradient of NaCl from 0 to 300 mm at a flow rate of 3 ml/min. Fractions of 6 ml were collected and assayed for protein and NT-degrading activity. The active fractions were pooled, concentrated by ultrafiltration and further purified by chromatography on HAUltrogel, MonoQ and alkyl-Superose in essentially the same manner as for the membrane-associated activity.
When starting with larger quantities of brain (500 g), a concentration step was used: after the initial low-speed centrifugation, the supernatant was subjected to a second centrifugation step (17000 g for 2 h) and (NH4)2SO4 was then added to this supernatant to achieve 60 % (w/v) saturation. This was stirred for 1 h at 4°C before centrifugation at 17000 g for 30 min. The resultant pellet was resuspended in 20 mM-Tris/HCI, pH 7.5, and was dialysed for 24-48 h against 2 x 9 litres of 20 mM-Tris/HCI, pH 7.5, prior to loading on to DEAE-cellulose. Subsequent steps were scaled up accordingly.
Purification of endopeptidase-24.15 I A post-microsomal supernatant was prepared from a homogenate of fresh pig brain as in the preparation of the membrane fraction which was the starting point for purifying the membrane-associated activity. (NH4)2S04 was slowly added to give a 60 % (w/v) saturation and the solution was stirred for 1 h at 4 'C. The resultant slurry was centrifuged at 17000 g for 30 min, producing a pellet which was taken up in 20 mmTris/HCl, pH 7.5, and then dialysed against the same buffer. Purification of the enzyme followed a similar sequence of chromatography steps to those for the membrane-associated and cytosolic enzyme activities described in the preceding two sections. The alkyl-Superose column, however, was replaced by a phenyl-Superose column using a descending gradient (1.7 M to zero) of (NH4)2S04 in 20 mM-Tris/HC1, pH 7.0.
H.p.l.c. analyses: peptidase assays and identification of products The assay mixture (100 ,u1 volume) contained 10 mM-Tris/HCl buffer, pH 7.0, 5 ,tM-phosphoramidon, 5 /M-captopril, S,UMamastatin and 0.5 mM-Dip-F. Enzyme samples were preincubated with inhibitors for 15 min at 37 'C before the addition of the peptide substrates. The concentration of NT was 0.5 mm unless stated otherwise. Incubations were terminated by heating at 100 'C for 4 min and the contents were centrifuged before h.p.l.c. analysis.
Assays for endopeptidase-24.15 contained 0.5 mM-dithiothreitol (DTT) and used the pooled active fractions from MonoQ chromatography.
Reaction products were resolved and quantified by reversephase h.p.l.c. A 15 min linear gradient of 10-30 % acetonitrile in 0.1 % trifluoroacetic acid followed by elution for 5 min at 30 % acetonitrile in 0.1 % trifluoroacetic acid was used to separate NT and its fragments. The flow rate was 1.7 ml/min. Under these conditions, NT-(1-8) was eluted at approx. 8 min, NT-(1-10) at 9.5 min and NT at 16.5 min. NT endopeptidase activity was normally assessed by quantifying NT-(1-10). The separation of the products of BocFAAFpAB, BzGAAFpAB and substance P Table 1 . Purification of membrane-associated NT endopeptidase activity from pig brain Samples from each fraction were assayed as described in the Experimental section. The extent of NT hydrolysis was in the range 5-10 %. Protein concentrations were determined by the method of Lowry et al. (1951) in all fractions except for the alkyl-Superose fraction, where the protein content was estimated from the A280 elution profile, and hence the specific activity and purification factor are shown in parentheses.
NT-(l-10)-producing activity hydrolysis employed a 20 min linear gradient of 4.5-45 % acetonitrile in 0.08 % H3PO4, followed by a 5 min elution at final conditions using a flow rate of 2 ml/min. All other peptides were separated on a 15 min linear gradient of 4.5-45 % acetonitrile in 0.08 % H3PO4 followed by a 5 min elution at final conditions using a flow rate of 1.5 ml/min. In experiments involving the collection of peptide products, some of the h.p.l.c. gradients were slightly extended for better peak separation: for NT, luliberin (LHRH) and angiotensins I and II, a 20 min linear gradient was followed by 5 min at final conditions, and for substance P, a 25 min linear gradient was followed by 5 min at final conditions with a flow rate of 1.5 ml/min. The unit of enzyme activity is
Amino acid composition of peptide fragments Peptide fragments collected after elution from the h.p.l.c. column were dried and hydrolysed for 18 h at 1 10°C in 200 ,1 of 6 M-HCI containing 0.03 % (w/v) phenol. They were dried again before their amino acid content was determined using a RankHilger Chromospek J-180 amino acid analyser and a Spectrophysics SP 4290 integrator.
N-Glycanase treatment
This was performed as described previously (Gee & Kenny, 1987) . The enzyme (3 jug of protein) was incubated with NGlycanase (0.1-0.5 unit) at 37°C for 18 h in 0.25 MNa2HP04/NaH2PO4 buffer, pH 8.6, containing 12 mM-l,I0-phenanthroline (incubation volume 25,l).
SDS/polyacrylamide gel electrophoresis
This was performed using the system of Laemmli (1970) 
RESULTS

Purification of membrane-associated NT endopeptidase
The bulk of the NT-degrading activity was associated with the supernatant fraction rather than the membrane pellet. When fresh brains were used, only 10% of the total NT-(l-10)-producing activity and 3% of that producing NT-(1-8) was associated with the washed membrane fraction, and these values fell to about 1 % when brains previously stored at -70°C before homogenization were used. The overall purification of NT Vol. 276 to the alkyl-Superose column as described in the Experimental section. A descending gradient (2 x 12.5 ml) of (NH4)2SO4 (2-0 M) in 50 mM-potassium phosphate buffer, pH 7.0, was applied at a flow rate of0.5 ml/min. Fractions (0.5 ml) were collected and 5 pUl samples (protein) is represented by the broken line. endopeptidase, i.e. that activity generating NT(l-10), was 900-fold from the membrane pellet, with an overall yield of 4.80% (Table 1) . A weaker activity hydrolysing the Arg8-Arg9 bond of NT was never dissociated from that hydrolysing the Pro'0-Tyr'1 bond, and achieved a constant ratio of about 1: 5 throughout the four chromatographic steps of the purification. The overall purification factor for this activity was somewhat lower (430-fold), but was essentially identical over the last four steps (Table  1) . In repeated preparations of the enzyme, the ratio of activities producing NT-(l-10) to those producing NT-(1-8) was also constant: at the MonoQ step it was 4.8+0.3 (mean+S.E.M., n = 5) and at the alkyl-Superose stage it was 4.9 + 0.3 (n = 4). Fig. 1 shows that the major protein peak eluted from alkylSuperose coincided with the activity producing NT-(l-10) and NT-(1-8). The pooled fractions from this peak also hydrolysed two substrates of endopeptidase-24. 15, BzGAAFpAB and BocFAAFpAB (Orlowski et al., 1983) , the latter with a specific activity of approx. 60 units/mg of protein. A sample was also subjected to SDS/PAGE and revealed a major polypeptide of Mr 75000 and a minor one at Mr 65000 (Fig. 2a) . Pretreatment The sample in this purification was subject to an (NH4)2SO4 concentration step, as described in the Experimental section, prior to the DEAE-cellulose column (160 ml bed volume). The pooled active fractions from DEAE were concentrated and dialysed against 1 mM-potassium phosphate buffer, pH 7.0, before application to hydroxyapatite (bed volume 175 ml) pre-equilibrated in the same buffer. The sample was eluted with a linear gradient (2 x 350 ml) from 1 mm-to 200 mM-potassium phosphate, pH 7.0, with a flow rate of 3.3 ml/min. Fractions of 6 ml were collected and 40,ul samples were assayed for NT (0.25 mM) degradation over a 1 h incubation time. Reaction products were measured by h.p.l.c. 0, NT-(1-8); *, NT-(l-10).
of the protein with N-Glycanase had no effect on the mobility of either polypeptide; a sample of aminopeptidase W treated in parallel was effectively deglycosylated (results not shown) as previously reported (Gee & Kenny, 1987) .
Purification of soluble NT endopeptidase Essentially the same chromatographic steps were used for the purification of the soluble activity. This resulted in an overall purification ofabout 800-folcd from the homogenate when assayed for the production of NT-(1-10) ( Table 2 ). The chromatographic behaviour of the soluble activity was identical to that for the membrane-associated activity. However, in contrast to the previous preparation from the membranes, the activity in the 3000 g supernatant hydrolysing the Arg8-Arg9 bond was 3-fold greater, but as purification proceeded the activity generating NT-(1-8) decreased and the ratio of the activity generating NT-(1-10) to Relative activity (% of control)
Membrane-associated activity that generating NT-(1-8) reached a value of 4.7. It was noteworthy that the last chromatographic step, alkyl-Superose, yielded two NT-degrading activity peaks (I and II) (Fig. 3) . In each, the relative activities yielding NT-(1-10) and NT-(1-8) were essentially similar. Both peaks of activity also hydrolysed BzGAAFpAB and BocFAAFpAB. The specific activity of the second peak for BocFAAFpAB was approx. 44 units/mg of protein, a value comparable with that for the membrane enzyme (60 units/mg). SDS/PAGE of the second of the two active peaks from alkyl-Superose revealed a major polypeptide constituent at Mr75000 (Fig. 2b) . The purified enzyme is recovered in the supernatant after centrifugation at 100000 g for 60 min, indicating a soluble activity.
Purification of endopeptidase-24.15
A second activity hydrolysing NT at the Arg8-Arg9 bond could be partially resolved from NT endopeptidase on HAUltrogel during the purification of the soluble (Fig. 4) and membrane-associated enzymes. In the latter case, this separation was only observed when the brains had been frozen. This second activity was assumed to represent endopeptidase-24.15, and the peak from the HA-Ultrogel column in which it was found (pool 1, Fig. 4 ) was used as the starting point for the purification of endopeptidase-24.15 (Table 3 ). The pooled fractions were virtually free of NT-(1-10)-producing activity, and this became undetectable after chromatography on MonoQ. The enzyme was eluted as a broad peak from phenyl-Superose but was not homogeneous on SDS/PAGE, where a major polypeptide of Mr 55000 was accompanied by several other peptide bands. This is somewhat lower than the Mr of endopeptidase-24. 15 Baz-Glyt4la-Ala-Hse-pAaB Fig. 5 . Sites of hydrolysis of peptides by the membrane-associated NT endopeptidase The data from which the sites were defined is given in Table 6 . The arrows ( +, I ) relate to the rates of hydrolysis indicated by the relative yields of the peptide products.
differ from other reports, where 1 mM-DTT produced a 65 % inhibition of rat NT endopeptidase (Barelli et al., 1988a ) and more modest increases in the activity of rat endopeptidase-24. 15 in crude preparations (Orlowski et al., 1983 (Orlowski et al., , 1989 .
Three inhibitors specifically designed for rat endopeptidase-24.15, CFEAAFpAB, CFPAAFpAB and CFPAAYpAB (Chu & Orlowski, 1984; Orlowski et al., 1988) , were equally effective on the three enzyme preparations. The degree of inhibition by CFEAAFpAB agrees closely with results quoted by Barelli et al. (1988a) . Phosphoramidon (1 ,UM), amastatin (1 /lM), captopril
(1 /vM) and Dip-F (0.1 mM) had no inhibitory action on NT endopeptidase activity from the membrane and soluble preparations.
It is noteworthy that the NT endopeptidase activity in peaks I and II from the alkyl-Superose step in the soluble preparation showed a similar sensitivity to phenanthroline, EDTA, DTT, CFEAAFpAB, LI 55212, phosphoramidon, amastatin, captopril and Dip-F (results not shown).
Hydrolysis of natural and synthetic peptides by NT endopeptidase
The NT endopeptidase activities purified from the membrane and soluble fractions of brain were not specific for NT. Both hydrolysed a diverse range of peptides. The hydrolysis rates of several peptides (Table 5) were compared using one of two methods. Linear time courses for the substrate disappearance over 4 h incubation periods were observed when log [peptide] was plotted against time, from which half-lives for the peptides were calculated. In other cases, the mean rates ofsubstrate degradation were calculated after set incubation times which ranged from 30 min to 3 h.
The synthetic endopeptidase-24.15 substrate BocFAAFpAB (Orlowski et al., 1983 ) was hydrolysed at a faster rate than the other peptides at 330 nm and was used as a standard against which the hydrolysis of the other peptides could be compared. Bradykinin and substance P were also degraded at a faster rate than was NT. In contrast, neuromedin N was hydrolysed slowly by both enzyme preparations, despite its similarity to NT in the residues around the site of hydrolysis.
In the soluble preparation, peaks I and II of NT endopeptidase from the alkyl-Superose step showed identical rates of hydrolysis of NT, NT-(l-l 1) and bradykinin relative to BocFAAFpAB degradation [NT-(l-l 1) was degraded at a rate 12% that of BocFAAFpAB (results not shown)].
Sites in natural and synthetic peptides hydrolysed by membrane NT endopeptidase
The sites of hydrolysis shown in Fig. 5 were determined in two ways. Where marker peptides were available, their retention times on h.p.l.c. could be compared with those of the degradation products from peptide hydrolysis: NT-(1-8) was used as a marker for the products of neurotensin hydrolysis; Tyr-Ile-Leu (produced from NT hydrolysis) was used as a marker with and neuromedin N; BocPhe was used as a marker for BocFAAFpAB; and the AAFpAB (produced from BocFAAFpAB hydrolysis) was used as a marker for BzGAAFpAB hydrolysis. Other products were identified by determining the composition by amino acid analysis. The evidence for the identity and the yield of each product is shown in Table 6 .
Although the sites hydrolysed by the membrane enzyme only are shown, similar patterns of product peaks from h.p.l.c. were also observed with cytosol NT endopeptidase, strongly suggesting that the two enzymes attacked the same bonds. Moreover, no differences were observed for peaks I and II in the soluble preparation in these experiments.
DISCUSSION
NT endopeptidase is a cytosolic enzyme By following the method of Checler et al. (1986) we have isolated NT endopeptidase from the membrane fraction of pig brain. The material recovered after chromatography on hydroxyapatite had a specific activity and yield similar to that purified by Checler et al. (1986) . However, the two extra chromatographic steps that we used produced a sample with specific activity and purification factor higher than the values quoted by both Checler Table 6 . Identification of peptides released by the membrane-associated NT endopeptidase See the Experimental section for details. Generally incubations were for 18 h, but for NT the incubation period was 5 h; and for NT-(1-l 1), dynorphin A-(1-8) and bradykinin it was 2 h. The number of separate incubations from which the peak fractions of product were pooled is shown in parentheses. The yields were determined from single incubations which contained 50 nmol of peptide, except in the case of a-neoendorphin and (Barelli et al., 1988a) , the remaining activity being present in the soluble fraction. NT It was a feature of both the soluble and membrane-associated activities that the production of NT-(1-10) was always acVol. 276 companied by a 5-fold lesser production of NT-(1-8), and the ratio of activities was constant in five different purifications. The minor cleavage yielding NT-(1-8) was not reported for NT endopeptidase isolated from the rat (Checler et al., 1986; Barelli et al., 1988a,b) . Hydrolysis at the Arg8-Arg9 position of NT, however, is a characteristic feature of endopeptidase-24.15 (Orlowski et al., 1983) , another peptidase in rat brain which, though mainly cytosolic, has a membrane-associated component (Chu & Orlowski et al., 1985; Acker et al., 1987) . This raised the important question: was our highly purified NT endopeptidase contaminated with endopeptidase-24.15? Our results argue strongly against this possibility. The first piece of evidence is the constant 5:1 ratio of formation of NT-(1-10) compared with NT-(1-8) during four chromatographic steps and in five different preparations. Secondly, the putative endopeptidase-24.15 activity hydrolysing the Arg8-Arg9 bond could be partially resolved by the HA-Ultrogel step and, when these fractions were subjected to further chromatography, the contaminating NT endopeptidase was removed. Thirdly, although endopeptidase-24.15 and NT endopeptidase had a number of similarities in their responses to chelating agents and to peptidase inhibitors, there were notable differences, i.e. the 5-fold activation by DTT and the lesser sensitivity to EDTA and L155212 of endopeptidase-24.15. The slow reaction of endopeptidase-24.15 with EDTA has also been noted by Tisljar & Barrett (1990) . Fourthly, the formation of the two NT fragments, NT-(1-10) and NT-(1-8), by NT endopeptidase responded identically to these three reagents.
There are also some differences in the properties of our preparation of pig brain NT endopeptidase and those noted by Checler's group for the rat enzyme which deserve comment. Most important is the consistently observed hydrolysis of the Arg8-Arg9 bond, not reported for the rat enzyme. Although there may be a species variation in this respect, a difference in methodology may also be an explanation. Our experiments used 500 fM-NT in the assays, 50 times greater than the concentration used by Checler's group, hence making the minor product more easily detected in the h.p.l.c. profile.
Other differences might suggest species variations. Thus the lack of inhibition by DTT of NT endopeptidase contrasts with results quoted by Barelli et al. (1988a) , who obtained a 650% inhibition. The 6-fold stimulation ofendopeptidase-24.15 activity also contrasts with the results of Orlowski et al. (1988) , who found only modest stimulation. Interestingly, inhibitors specifically designed for rat endopeptidase-24.15 (Poszgay et al., 1986; Orlowski et al., 1988) were equally effective with the NT endopeptidase and pig endopeptidase-24.15. However, the degree of inhibition produced in the pig endopeptidase-24.15 was rather low compared with the reported K1 values for CFEAAFpAB, CFPAAFpAB and CFPAAYpAB (2^, 27 nm and 16 nm respectively) (Chu & Orlowski, 1984; Orlowski et al., 1988) . It is possible that this could be attributed to species difference, since rabbit endopeptidase-24.15 has been reported to retain 700% of its activity in the presence of 2 1M-CFPAAFpAB (Tisljar & Barrett, 1990) . These inhibitors may therefore be less specific for endopeptidase-24.15 in species other than the rat.
NT endopeptidase is not peptide-specific Although NT endopeptidase from rat brain has been reported to degrade neuromedin N and xenopsin at their Pro-Tyr bonds (Checler et al., 1986) and also several other peptides, namely angiotensins I and II, dynorphins-(1-8) and bradykinin (Barelli et al., 1988a,b) , few details were given. Our results showed that many more peptides were hydrolysed, some more rapidly than NT, a point which must question the suitability of the ECapproved name NT endopeptidase. The bonds cleaved in these peptides indicate that the specificity of the enzyme is not definable in simplistic terms. Many of the hydrolysis sites are identical with those attacked by endopeptidase-24.15 (Orlowski et al., 1983; Chu & Orlowski, 1985; Acker et al., 1987; Camargo et al., 1987) , for which the presence of L-aromatic residues in positions P1, P2 and P'3 are favourable, the active site being thought to accommodate at least five residues. For NT endopeptidase, a number of dipeptides have been tested as competitive inhibitors. These studies showed that the most potent inhibitors contained the Pro-Xaa sequence where Xaa was an aromatic or hydrophobic residue (Barrelli et al., 1988a,b) , but it is clear that Pro at P1 is not essential for the activity of this enzyme.
Chain length is also an important factor determining the site of attack by NT endopeptidase, as has been found for endopeptidase-24. 15, where the hydrolysis of a 7-residue enkephalincontaining peptide released Tyr-Gly-Gly-Phe, but the hydrolysis of enkephalin-containing peptides of 8-13 residues generated enkephalin as a major product (Camargo et al., 1987) . NT endopeptidase generated both Tyr-Gly-Gly-Phe and enkephalin as products of dynorphin A-(1-8) hydrolysis, but only one product, enkephalin, was generated from [Leu5]enkephalinArg6-Lys7-Arg8.
Conclusions
The enzyme NT endopeptidase is not NT-specific and a more appropriate name, such as endopeptidase-24.16, would avoid confusion, such a name also serving to emphasize that it is distinct from endopeptidase-24.15. Nonetheless, the similarities of these two enzymes are more striking than their differences. In brain, both are predominantly cytosolic, and the membraneassociated component is clearly not indicative of an integral membrane protein or of an ectoenzyme. It is therefore difficult to envisage a role for these peptidases in either peptide processing within intracellular membrane-bound compartments or in neuropeptide metabolism after release from synapses. Their natural intracellular substrates are as yet unclear.
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